Predict your next investment

Family Office

See what CB Insights has to offer

Investments

7

Portfolio Exits

3

About Chione

Chione Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Chione

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Chione in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest Chione News

Sera Prognostics Raises $36M in Series D Financing

Nov 13, 2019

Sera Prognostics , a Salt Lake City, Utah-based health diagnostics company focused on women and babies through individualized prenatal care, raised $36m in Series D financing. The round was led by Blue Ox Healthcare Partners alongside two strategic healthcare companies and participation from existing investors Domain Associates, InterWest Partners, Laboratory Corporation of America Holdings, Catalyst Health Ventures, and Chione Ltd. The company intends to use the funds to increase commercialization of its test and to measure real-world clinical improvements and economic savings in collaboration with top health plans and providers. Led by Gregory C. Critchfield, MD, MS, Chairman and Chief Executive Officer, Sera Prognostics is advancing the PreTRM® test, a clinically-validated, commercially available biomarker blood test that accurately assesses a woman’s individualized risk of premature delivery. The blood test provides an early and individual risk prediction for spontaneous preterm birth in asymptomatic, singleton pregnancies and measures and analyzes proteins in the blood that are highly predictive of preterm birth. FinSMEs 13/11/2019

Chione Investments

7 Investments

Chione has made 7 investments. Their latest investment was in Sera Prognostics as part of their Series D on August 8, 2019.

CBI Logo

Chione Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/7/2019

Series D

Sera Prognostics

$36M

No

Blue Ox Capital, Catalyst Health Ventures, Domain Associates, InterWest Partners, LabCorp, and Upstart Venture

5

2/28/2017

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

7/11/2016

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

1/7/2015

Series B

Subscribe to see more

$99M

Subscribe to see more

10

5/20/2013

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/7/2019

2/28/2017

7/11/2016

1/7/2015

5/20/2013

Round

Series D

Seed VC - II

Seed VC

Series B

Series B

Company

Sera Prognostics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$36M

$99M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Blue Ox Capital, Catalyst Health Ventures, Domain Associates, InterWest Partners, LabCorp, and Upstart Venture

Sources

5

10

10

10

10

Chione Portfolio Exits

3 Portfolio Exits

Chione has 3 portfolio exits. Their latest portfolio exit was Sera Prognostics on July 16, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/16/2021

IPO

$991

1

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

7/16/2021

00/00/0000

00/00/0000

Exit

IPO

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.